Pharmacist prescribing practices in a clinical pharmacy cardiac risk service

American Journal of Health-System Pharmacy

Volumn 73, Issue 18, 2016, Pages 1442-1450

  Todd, Brittany A ^a,b   Lamprecht, Donald G ^a,b   Stadler, Sheila L ^a,b  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CLINICAL OUTCOME; CLINICAL PHARMACY; COLORADO; CORONARY ARTERY ATHEROSCLEROSIS; COST CONTROL; DIABETES MELLITUS; DYSLIPIDEMIA; FOLLOW UP; HEALTH CARE COST; HEALTH MAINTENANCE ORGANIZATION; HEALTH SERVICE; HUMAN; HYPERTENSION; MEDICATION COMPLIANCE; MEDICATION THERAPY MANAGEMENT; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT SAFETY; PHARMACIST; PRESCRIPTIVE AUTHORITY; PRIORITY JOURNAL; REVIEW; SCOPE OF PRACTICE; SECONDARY PREVENTION; CARDIOVASCULAR DISEASE; HEALTH CARE POLICY; HOSPITAL PHARMACY; INTERSECTORAL COLLABORATION; PRESCRIPTION; PROFESSIONAL STANDARD; RISK FACTOR; STANDARDS; TRENDS; UNITED STATES;

CARDIOVASCULAR DISEASES; COLORADO; DRUG PRESCRIPTIONS; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INTERSECTORAL COLLABORATION; PATIENT CARE TEAM; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PHARMACISTS; PHARMACY SERVICE, HOSPITAL; PROFESSIONAL ROLE; RISK FACTORS; UNITED STATES;

EID: 84987850193     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp150781     Document Type: Review

References (17)

1. Levy J. In U.S., uninsured rate dips to 11.9% in first quarter (April 13, 2015). www.gallup.com/poll/182348/uninsured-rate-dips-first-quarter.aspx (accessed 2015 Sep 9).
2. Avalere Health LLC. Exploring pharmacists' role in a changing healthcare environment (May 2014). http://assets.fiercemarkets.net/public/Pharmacist%20Report.pdf (accessed 2016 Jan 27).
3. Pullen LC. AMA does not want pharmacists to prescribe medication. Presentation at AMA 2012 Annual Meeting. Chicago, IL; 2012 Jun 22.
4. Merenich JA, Lousberg GT, Brennan SH et al. Optimizing treatment of dyslipidemia in patients with coronary artery disease in the managed-care environment (the Rocky Mountain Kaiser Permanente experience). Am J Cardiol. 2000; 85:36A-42A.
5. Sueta CA, Chowdhury M, Boccuzzi JS et al. Analysis of the degree of undertreatment of hyperlipidemia and congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1999; 83:1303-7.
6. Sandhoff BG, Nies LK, Olson KL et al. Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organization. Am J Health-Syst Pharm. 2007; 64:77-84.
7. Senate Bill 15-192. Section 1. Colorado revised statutes, 12-42.5-102. www.leg.state.co.us/clics/clics2015a/csl.nsf/fsbillcont2/5C1A5B10580C113687257DDA007EA9E6/$FILE/192-enr.pdf (accessed 2015 Sep 15).
8. Department of Regulatory Agencies. State board of pharmacy rules 3 CCR 719-1. Proposed rule amendments. Rule 6.00.30 (September 14, 2015). www.colorado.gov/pacific/dora/Pharmacy-Laws#Rules (accessed 2016 Feb 25).
9. Stone NJ, Robinson J, Lichtenstein AH et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. A report to the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129:S1-45.
10. Jacobson TA, Ito MK, Maki KC et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - full report. J Clin Lipidol. 2015; 9:1-41.
11. Weber MA, Schiffrin EL, White WB et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens. 2014; 16:14-26.
12. James PA, Oparil S, Carter BL et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311:507-20.
13. Standards of medical care in diabetes - 2015: summary of revisions. Diabetes Care. 2015; 38:S4-46.
14. Holsclaw SL, Olson KL, Hornak R, Denham AM. Telephone and mail interventions provided by a clinical pharmacy cardiac risk reduction service. J Manag Care Pharm. 2005; 11:403-9.
15. Sandhoff BG, Kuca S, Rasmussen J, Merenich JA. Collaborative cardiac care service: a multidisciplinary approach to caring for patients with coronary artery disease. Perm J. 2008; 12(3):4-11.
16. Merenich JA, Olson KL, Delate T et al. Mortality reduction benefits of a comprehensive cardiac care program for patients with occlusive coronary artery disease. Pharmacotherapy. 2007; 27:1370-8.
17. Delate T, Olson KL, Rasmussen J et al. Reduced healthcare expenditures after enrollment in a collaborative cardiac care service. Pharmacotherapy. 2010; 30:1127-35.